The Australian biotechnology industry is itching to grow up. Despite decades of world-class discoveries in science, it is a young industry by world standards, and is just starting to find its commercial feet. Charles Beckley reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Author notes
Charles Beckley is a freelance business writer based in Melbourne, Australia.
- Charles Beckley
Rights and permissions
About this article
Cite this article
Beckley, C. Biotech business Down Under. Nature 429, 5–9 (2004). https://doi.org/10.1038/429a05a
Issue Date:
DOI: https://doi.org/10.1038/429a05a
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.